S

SanRo Clinical Research Group | Bryant, AR

Research site
(Unclaimed)
Location
3005 Corporate Center Drive, Bryant, Arkansas, United States of America
Site insights

Top conditions

Type 2 Diabetes Mellitus (1 trial)

Depression (1 trial)

Depressive Disorder (1 trial)

Post-Traumatic Stress Disorders (1 trial)

Diabetes Mellitus (1 trial)

Top treatments

LY3502970
Orforglipron
SEP-4199
Metformin
JZP150

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

1 of 3
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor (ACHIEVE-5)

The main purpose of this study is to determine the safety and efficacy of orforglipron. Participants will have Type 2 Diabetes (T2D) and have inadequ...

Enrolling
Type 2 Diabetes
Drug: Orforglipron
Drug: Placebo

Trial sponsors

Jazz Pharmaceuticals logo

Jazz Pharmaceuticals (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems